{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:52:28Z","timestamp":1789537948206,"version":"build-2803163510"},"reference-count":39,"publisher":"Japan Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1507\/endocrj.ej17-0036","type":"journal-article","created":{"date-parts":[[2017,7,12]],"date-time":"2017-07-12T22:04:58Z","timestamp":1499897098000},"page":"895-906","source":"Crossref","is-referenced-by-count":35,"title":["Atypical pituitary adenoma with &lt;i&gt;MEN1&lt;\/i&gt; somatic mutation associated with abnormalities of DNA mismatch repair genes; &lt;i&gt;MLH1&lt;\/i&gt; germline mutation and &lt;i&gt;MSH6&lt;\/i&gt; somatic mutation"],"prefix":"10.1507","volume":"64","author":[{"given":"Shinsuke","family":"Uraki","sequence":"first","affiliation":[{"name":"The 1st Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Ariyasu","sequence":"additional","affiliation":[{"name":"The 1st Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asako","family":"Doi","sequence":"additional","affiliation":[{"name":"The 1st Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Furuta","sequence":"additional","affiliation":[{"name":"The 1st Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nishi","sequence":"additional","affiliation":[{"name":"The 1st Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kokichi","family":"Sugano","sequence":"additional","affiliation":[{"name":"Oncogene Research Unit\/Cancer Prevention Unit, Tochigi Cancer Center Research Institute, Tochigi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Inoshita","sequence":"additional","affiliation":[{"name":"Department of Pathology, Toranomon Hospital, Tokyo 105-8470, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Nakao","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Wakayama Medical University, Wakayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shozo","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Hypothalamic and Pituitary Surgery, Toranomon Hospital, Tokyo 105-8470, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Akamizu","sequence":"additional","affiliation":[{"name":"The 1st Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Daly AF, Tichomirowa MA, Beckers A (2009) The epidemiology and genetics of pituitary adenomas. <i>Best Pract Res Clin Endocrinol Metab<\/i> 23: 543-554.","DOI":"10.1016\/j.beem.2009.05.008"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ezzat S, Asa SL (2006) Mechanisms of disease: The pathogenesis of pituitary tumors. <i>Nat Clin Pract Endocrinol Metab<\/i> 2: 220-230.","DOI":"10.1038\/ncpendmet0159"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Melmed S (2003) Mechanisms for pituitary tumorigenesis: the plastic pituitary. <i>J Clin Invest<\/i> 112: 1603-1618.","DOI":"10.1172\/JCI20401"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Asa SL, Ezzat S (2009) The pathogenesis of pituitary tumors. <i>Annu Rev Pathol<\/i> 4: 97-126.","DOI":"10.1146\/annurev.pathol.4.110807.092259"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Yacqub-Usman K, Richardson A, Duong CV, Clayton RN, Farrell WE (2012) The pituitary tumor epigenome: aberrations and prospects for targeted therapy. <i>Nat Rev Endocrinol<\/i> 8: 486-494.","DOI":"10.1038\/nrendo.2012.54"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Fukuoka H, Takahashi Y (2014) The role of genetic and epigenetic changes in pituitary tumorigenesis. <i>Neurol Med Chir (Tokyo)<\/i> 54: 943-957.","DOI":"10.2176\/nmc.ra.2014-0184"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hewish M, Lord CJ, Martin SA, Cunningham D, Ashworth A, <i>et al<\/i>. (2010) Mismatch repair deficient colorectal cancer in the era of personalized treatment.<i> Nat Rev Clin Oncol<\/i> 7: 197-208.","DOI":"10.1038\/nrclinonc.2010.18"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Martin SA, Lord CJ, Ashworth A (2010) Therapeutic targeting of the DNA mismatch repair pathway. <i>Clin Cancer Res<\/i> 16: 5107-5113.","DOI":"10.1158\/1078-0432.CCR-10-0821"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Pe&ntilde;a-Diaz J, Jiricny J (2012) Mammalian mismatch repair: error-free or error-prone? <i>Trends Biochem Sci<\/i> 37: 206-214.","DOI":"10.1016\/j.tibs.2012.03.001"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Mart&iacute;n-L&oacute;pez JV, Fishel R (2013) The mechanism of mismatch repair and the functional analysis of mismatch repair defects in Lynch syndrome. <i>Fam Cancer<\/i> 12: 159-168.","DOI":"10.1007\/s10689-013-9635-x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Lynch HT, de la Chapelle A (2003) Hereditary colorectal cancer. <i>N Engl J Med<\/i> 348: 919-932.","DOI":"10.1056\/NEJMra012242"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Tiwari AK, Roy HK, Lynch HT (2016) Lynch syndrome in the 21st century: clinical perspectives. <i>QJM<\/i> 109: 151-158.","DOI":"10.1093\/qjmed\/hcv137"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Mei M, Deng D, Liu TH, Sang XT, Lu X, <i>et al<\/i>. (2009) Clinical implications of microsatellite instability and MLH1 gene inactivation in sporadic insulinomas. <i>J Clin Endocrinol Metab<\/i> 94: 3448-3457.","DOI":"10.1210\/jc.2009-0173"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Sumitsuji I, Sugano K, Matsui T, Fukayama N, Yamaguchi K, <i>et al<\/i>. (2003) Frequent genomic disorganisation of MLH1 in hereditary non-polyposis colorectal cancer (HNPCC) screened by RT-PCR on puromycin treated samples. <i>J Med Gene<\/i>t 40: e30.","DOI":"10.1136\/jmg.40.3.e30"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Tanaka Y, Hongo K, Tada T, Sakai K, Kakizawa Y, <i>et al<\/i>. (2003) Growth pattern and rate in residual nonfunctioning pituitary adenomas: correlations among tumor volume doubling time, patient age, and MIB-1 index. <i>J Neurosurg<\/i> 98: 359-365.","DOI":"10.3171\/jns.2003.98.2.0359"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Hsu CY, Guo WY, Chien CP, Ho DM (2010) MIB-1 labeling index correlated with magnetic resonance imaging detected tumor volume doubling time in pituitary adenoma. <i>Eur J Endocrinol<\/i> 162: 1027-1033.","DOI":"10.1530\/EJE-09-1100"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Monsalves E, Larjani S, Loyola Godoy B, Juraschka K, Carvalho F, <i>et al<\/i>. (2014) Growth patterns of pituitary adenomas and histopathological correlates. <i>J Clin Endocrinol Metab<\/i> 99: 1330-1338.","DOI":"10.1210\/jc.2013-3054"},{"key":"18","unstructured":"18. DeLellis RA, Lloyd R, Heitz PU, eds. 2004 WHO Classification of Tumors, Pathology and Genetics: Tumors of Endocrine Organs. Lyon, France: IARC Press."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Yamaguchi T, Iijima T, Mori T, Takahashi K, Matsumoto H, <i>et al<\/i>. (2006) Accumulation profile of frameshift mutations during development and progression of colorectal cancer from patients with hereditary nonpolyposis colorectal cancer. <i>Dis Colon Rectum<\/i> 49: 399-406.","DOI":"10.1007\/s10350-005-0293-4"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, <i>et al<\/i>. (1997) Positional cloning of the gene for multiple endocrine neoplasia-type 1. <i>Science<\/i> 276: 404-407.","DOI":"10.1126\/science.276.5311.404"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Lemmens I, Van de Ven WJ, Kas K, Zhang CX, Giraud S, <i>et al<\/i>. (1997) Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. <i>Hum Mol Genet<\/i> 6: 1177-1183.","DOI":"10.1093\/hmg\/6.7.1177"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Pei L, Melmed S (1997) Isolation and characterization of a pituitary tumor-transforming gene (PTTG). <i>Mol Endocrinol<\/i> 11: 433-441.","DOI":"10.1210\/mend.11.4.9911"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Lemos MC, Thakker RV (2008) Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. <i>Hum Muta<\/i> 29: 22-32.","DOI":"10.1002\/humu.20605"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Agarwal SK, Kennedy PA, Scacheri PC, Novotny EA, Hickman AB, <i>et al<\/i>. (2005) Menin molecular interactions: insights into normal functions and tumorigenesis. <i>Horm Metab Res<\/i> 37: 369-374.","DOI":"10.1055\/s-2005-870139"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Balogh K, R&aacute;cz K, Pat&oacute;cs A, Hunyady L (2006) Menin and its interacting proteins: elucidation of menin function. <i>Trends Endocrinol Metab<\/i> 17: 357-364.","DOI":"10.1016\/j.tem.2006.09.004"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Kaji H, Canaff L, Lebrun JJ, Goltzman D, Hendy GN (2001) Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling. <i>Proc Natl Acad Sci U S A<\/i> 98: 3837-3842.","DOI":"10.1073\/pnas.061358098"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Busygina V, Kottemann MC, Scott KL, Plon SE, Bale AE (2006) Multiple endocrine neoplasia type 1 interacts with forkhead transcription factor CHES1 in DNA damage response. <i>Cancer Res<\/i> 66: 8397-8403.","DOI":"10.1158\/0008-5472.CAN-06-0061"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Schnepp RW, Hou Z, Wang H, Petersen C, Silva A, <i>et al<\/i>. (2004) Functional interaction between tumor suppressor menin and activator of S-phase kinase. <i>Cancer Res<\/i> 64: 6791-6796.","DOI":"10.1158\/0008-5472.CAN-04-0724"},{"key":"29","unstructured":"29. Pannett AA, Thakker RV (1999) Multiple endocrine neoplasia type 1. <i>Endocr Relat Cancer<\/i> 6: 449-473."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Bettuzzi S, Hiipakka RA, Gilna P, Liao ST (1989) Identification of an androgen-repressed mRNA in rat ventral prostate as coding for sulphated glycoprotein 2 by cDNA cloning and sequence analysis. <i>Biochem J<\/i> 257: 293-296.","DOI":"10.1042\/bj2570293"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Cheng CY, Chen CL, Feng ZM, Marshall A, Bardin CW (1988) Rat clusterin isolated from primary Sertoli cell-enriched culture medium is sulfated glycoprotein-2 (SGP-2). <i>Biochem Biophys Res Commun<\/i> 155: 398-404.","DOI":"10.1016\/S0006-291X(88)81099-4"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Chen X, Halberg RB, Ehrhardt WM, Torrealba J, Dove WF (2003) Clusterin as a biomarker in murine and human intestinal neoplasia. <i>Proc Natl Acad Sci U S A<\/i> 100: 9530-9535.","DOI":"10.1073\/pnas.1233633100"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Sala A, Bettuzzi S, Pucci S, Chayka O, Dews M, <i>et al<\/i>. (2009) Regulation of CLU gene expression by oncogenes and epigenetic factors implications for tumorigenesis. <i>Adv Cancer Res<\/i> 105: 115-132.","DOI":"10.1016\/S0065-230X(09)05007-6"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Chesnokova V, Zonis S, Zhou C, Ben-Shlomo A, Wawrowsky K, <i>et al<\/i>. (2011) Lineage-specific restraint of pituitary gonadotroph cell adenoma growth. <i>PLoS One<\/i> 6: e17924.","DOI":"10.1371\/journal.pone.0017924"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Chesnokova V, Zonis S, Wawrowsky K, Tani Y, Ben-Shlomo A, <i>et al<\/i>. (2012) Clusterin and FOXL2 act concordantly to regulate pituitary gonadotroph adenoma growth. <i>Mol Endocrinol<\/i> 26: 2092-2103.","DOI":"10.1210\/me.2012-1158"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Schult D, H&ouml;lsken A, Siegel S, Buchfelder M, Fahlbusch R, <i>et al<\/i>. (2015) EZH2 is highly expressed in pituitary adenomas and associated with proliferation. <i>Sci Rep<\/i> 5: 16965.","DOI":"10.1038\/srep16965"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Yoshioka K, Yoshioka Y, Hsieh P (2006) ATR kinase activation mediated by MutSalpha and MutLalpha in response to cytotoxic O6-methylguanine adducts. <i>Mol Cell<\/i> 24: 501-510.","DOI":"10.1016\/j.molcel.2006.04.023"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Hirohata T, Asano K, Ogawa Y, Takano S, Amano K, <i>et al<\/i>. (2013) DNA mismatch repair protein (MSH6) correlated with the responses of atypical pituitary adenomas and pituitary carcinomas to temozolomide: the national cooperative study by the Japan Society for Hypothalamic and Pituitary Tumors. <i>J Clin Endocrinol Metab<\/i> 98: 1130-1136.","DOI":"10.1210\/jc.2012-2924"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Murakami M, Mizutani A, Asano S, Katakami H, Ozawa Y, <i>et al<\/i>. (2011) A mechanism of acquiring temozolomide resistance during transformation of atypical prolactinoma into prolactin-producing pituitary carcinoma: case report. <i>Neurosurgery<\/i> 68: E1761-1767.","DOI":"10.1227\/NEU.0b013e318217161a"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/64\/9\/64_EJ17-0036\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,29]],"date-time":"2019-09-29T20:45:47Z","timestamp":1569789947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/64\/9\/64_EJ17-0036\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej17-0036","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}